January 13, 2026- Cardinal Health provided an update to its financial outlook for fiscal year 2026 and plans to highlight significant progress with its strategic growth initiatives during the 44th Annual J.P. Morgan Healthcare Conference.
Raising Fiscal 2026 Outlook
Cardinal Health is raising expectations for fiscal year 2026 non-GAAP diluted EPS to at least $10.00, from its prior guidance range of $9.65 to $9.85. This increased outlook is driven by strong performance and execution across the company’s five operating segments. The company will provide further details and updates on its upcoming second quarter earnings call on February 5, 2026.
Accelerating Specialty Growth
Cardinal Health now anticipates over $50 billion of Specialty revenues in fiscal year 2026, which represents a 16% CAGR over three years2. This growth is driven by robust demand across specialty distribution, the expansion of the company’s MSO platforms and over 30% anticipated revenue growth in BioPharma Solutions in fiscal 2026.
Continue Reading from Cardinal Health here.